Explore practical approaches to evaluating executive dysfunction and emotional dysregulation in ADHD and considerations for addressing persistent functional impairment beyond core symptoms.
Explore practical approaches to evaluating executive dysfunction and emotional dysregulation in ADHD and considerations for addressing persistent functional impairment beyond core symptoms.
Explore practical approaches to...
08/19/2026
Psych Congress Network
Sponsored
Beneath the Surface: The Importance of Assessing Executive Dysfunction and Emotional Dysregulation in ADHD
Learn about executive dysfunction and emotional dysregulation as common and clinically meaningful features of ADHD that extend beyond core symptoms and contribute to functional impairment across multiple areas of daily life.
Learn about executive dysfunction and emotional dysregulation as common and clinically meaningful features of ADHD that extend beyond core symptoms and contribute to functional impairment across multiple areas of daily life.
Learn about executive...
08/19/2026
Psych Congress Network
Sponsored
ADHD Neurobiology: How NE/DA/5-HT Interplay Shapes Clinical Presentation and Management
Experts discuss the interconnected roles of dopamine, norepinephrine, and serotonin in ADHD and examine how this framework may inform assessment of residual symptoms and treatment planning.
Experts discuss the interconnected roles of dopamine, norepinephrine, and serotonin in ADHD and examine how this framework may inform assessment of residual symptoms and treatment planning.
Experts discuss the...
08/19/2026
Psych Congress Network
Sponsored
ADHD Neurobiology: How NE/DA/5-HT Interplay Shapes Clinical Presentation and Management
Review the evolving understanding of ADHD neurobiology and how the interplay among dopamine, norepinephrine, and serotonin may help explain the broader clinical presentation of ADHD.
Review the evolving understanding of ADHD neurobiology and how the interplay among dopamine, norepinephrine, and serotonin may help explain the broader clinical presentation of ADHD.
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
